Latest Articles

David A. Drew, of Massachusetts General Hospital and Harvard Medical School, explains, during the virtual COVID-19 and cancer meeting, how smartphone applications are able to facilitate the collection of self-reported data at scale. He discusses how data collected using the COVID-19 Symptom Study app has helped investigate COVID-19’s impact on racial and ethnic minority communities, and those living with cancer.

In the second of our exclusive three-part interview series with Blue Brain Project Founder and Director Professor Henry Markram, we discuss how brain simulations can benefit neuroscience.

To keep the scientific community abreast of the continuous stream of new research data related to COVID-19 and cancer, on July 20, the American Association for Cancer Research (AACR) launched a three-day virtual COVID-19 and cancer meeting. Here, we highlight the main points discussed in the opening sessions.

Green spaces are a vital benefit to our mental health that can mitigate some of the difficulties of social isolation, reaffirmed research presented last week at FENS Virtual Forum of Neuroscience.

The EPFL Blue Brain Project (BBP) is a Swiss National Research Infrastructure project which has spent the last 15 years trying to advance the cause of simulation neuroscience. Through successes and headwinds, the BBP has been led since inception by Professor Henry Markram. Read all three parts of our exclusive interview series with Markram now.

Researchers are using sequencing technologies to rapidly expand our knowledge of the human microbiome and identify undiscovered bacterial genomes.

In the first of our exclusive three-part interview series with Blue Brain Project Founder and Director Professor Henry Markram, we discuss the basics of simulation neuroscience. Markram, one of the leading proponents of the field, comments on why the idea of simulating the brain has raised concerns from experimental and theoretical neuroscientists and answers whether in silico techniques could ultimately replace experimental approaches.

In this article, we explore recent developments related to cell-based phenotypic screening, discuss the elements of a good phenotypic drug screen, and discover how these approaches are helping to provide a more accurate biological context for drug screening.

Research into developing treatments for psychiatric illness is missing out vital data from female animals, producing drugs that aren’t optimized for women and contributing to the failure of clinical trials, said a panel of neuroscientists today at FENS Virtual Forum of Neuroscience.

Bristol University have announced that the Clinical Research and Imaging Center (CRICBristol), a joint venture with University Hospitals Bristol NHS Foundation Trust, will close at the end of December, putting six jobs at risk and throwing dozens of research projects into jeopardy.